COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with Chronic Obstructive Pulmonary Disease (COPD), a long-term lung condition that makes breathing difficult.
- People who experience mucus-related problems (such as coughing up mucus) at least 3 times per week.
- People who can speak and write in Norwegian.
- People who are able to use a smartphone and/or iPad on their own, without assistance.
Who may not be able to join:
- People who have a serious mental illness.
- People whose substance use would prevent them from taking part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bente Frisk, PHD, Western Norway University of Applied Sciences
Phone: 0047- 55587143
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment rate; Intervention adherence; Adverse events; Dropout rate; Health related outcomes; Health related outcomes; Health related outcomes; Health related outcomes; Health related outcome; Health related outcome; Health related outcomes; Health related outcomes; Physical functioning; Exacerbations, hospital admissions and use of healthcare services; Health literacy; Health literacy; Health education and self-management; Satisfaction with treatment; Satisfaction with treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.